MyAverix Finance
F · Healthcare
LEE S PHARMACEUTIC.HD-05 (L1PA)
Drug Manufacturers - Specialty & Generic
LEE S PHARMACEUTIC.HD-05 (L1PA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $81.54M, P/E ratio is 6.55, net margin is 6.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for L1PA
LEE S PHARMACEUTIC.HD-05 (L1PA) — FAQ
What is LEE S PHARMACEUTIC.HD-05's market cap?
LEE S PHARMACEUTIC.HD-05 (L1PA) has a reported market cap of $81.54M (data as of 2026-03-29).
What is L1PA's P/E ratio?
The price-to-earnings (P/E) ratio for LEE S PHARMACEUTIC.HD-05 (L1PA) is 6.55 (data as of 2026-03-29).
Does LEE S PHARMACEUTIC.HD-05 pay a dividend?
Dividend yield is not available in the current snapshot for LEE S PHARMACEUTIC.HD-05 (L1PA). Check the MyAverix Finance app for the latest dividend data.
What sector is LEE S PHARMACEUTIC.HD-05 in?
LEE S PHARMACEUTIC.HD-05 (L1PA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is L1PA listed on?
L1PA is listed on F.
What is LEE S PHARMACEUTIC.HD-05's net margin?
LEE S PHARMACEUTIC.HD-05 (L1PA) reports a net margin of 6.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.